Bruce Turner, M.D., Ph.D.
Dr. Turner is a medically trained radiation oncologist with deep experience transcending genetic research, drug development and healthcare portfolio management. Since 2017, Dr. Turner has served as Managing Director at Boxer Capital of Tavistock Group. He also spent five years at Hoffman-La Roche in various positions and helped lead the re-organization of the cardiovascular franchise among other responsibilities. Prior to joining Roche, Dr. Turner was vice president of Ionis Pharmaceuticals, Inc. working in cardiovascular drug development and business development. Earlier in his career, he served as a healthcare equities portfolio manager at Bank of America Merrill Lynch and Diker Management. Dr. Turner received a M.D. from the University of Pennsylvania School of Medicine, Ph.D. in Molecular Biology from the University of Pennsylvania School of Medicine, and B.A. degree in biology from the University of Chicago. He completed his postgraduate medical training at Yale-New Haven Hospital in Radiation Oncology and performed postdoctoral research at Yale University School of Medicine in the Department of Genetics.